MedTrace Logo

Efficacy Study of Oral Collagen Peptide on Skin Condition Improvement

NCT06847035 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-02-28

No results posted yet for this study

Summary

To assess if oral intake of collagen peptide can improve skin conditions such as skin thickness, density and firmness.

Conditions

  • Skin Aging

Interventions

DIETARY_SUPPLEMENT

Active Comparator

LISAVEI collagen peptide solid beverage ( contain 5 g collagen peptide)，once daily for 12 weeks

DIETARY_SUPPLEMENT

Placebo Comparator

placebo solid beverage (Maltodextrin with edible flavor)，once daily for 12 weeks

Sponsors & Collaborators

  • Shanghai Meifute Biotechnology Co., Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-25
Primary Completion
2024-11-19
Completion
2024-11-19

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06847035 on ClinicalTrials.gov